A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

A Spanish study found that the mortality rates of patients with digoxin poisoning in emergency departments (EDs) were 4.5% at 7 days and 11.1% at 30 days and that cardiovascular and neurologic ...

We had an older female with chronic kidney disease who started complaining about seeing yellow lights and being short of breath. She had a history of heart failure and was treated with digoxin. When ...

Evaluation of the drug by Canadian regulatory authorities is under way. Paladin Labs will take over distribution of BTG’s treatment for digoxin toxicity or overdose in Canada. DigiFab™ is currently ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

THE heightened sensitivity of the diseased myocardium to digitalis, as manifested by toxic responses to average or small doses, is well established. 1 Chelating compounds that act by removing calcium ...

Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding ...

Little is known about the efficacy and risk of different serum digoxin concentrations (SDC). The Digitalis Investigation Group (DIG) trial, a randomized, placebo-controlled study, has concluded that ...

THE ascendancy of digitalis intoxication in recent years has made this problem and its recognition an ever important clinical consideration in every patient receiving the drug. Much of this increase ...

Many people use apple cider vinegar daily, but it can negatively interact with common medications.What you can do: It’s best to check with a doctor about potential interactions with your current ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...